Publication dates

Cancer Immunotherapy Industry, September 2014 Market Research & Statistics

You might be interested in: vaccine

1-10 of about 200 reports for Cancer Immunotherapy

Pathology Description in India - Forecast

  • Media Coverage of Canmabtm Launch Announcement, Jan 18, 2014
  • January 2014
    50 pages
  • Breast Cancer  

    Cancer  

    Drug  

  • India  

    World  

View report >

Pathology Industry - Investor Report, April 2014

  • Innovative Science Affordable Medicine
  • April 2014
    48 pages
  • Insulin  

    Biosimilars  

  • India  

    World  

View report >

Pathology Description in the US - Forecast

  • Umbrella Research
  • January 2012
    33 pages
  • Cancer  

    Crohn's Disease  

  • United States  

View report >

Pathology Description in the US - Forecast

  • Umbrella Research
  • January 2012
    33 pages
  • Cancer  

    Crohn's Disease  

  • United States  

View report >

Bms - Annual Report, 2012

  • 2012 Annual Report
  • January 2012
    104 pages
  • United States  

View report >

Medigene - Annual Report, 2013

  • Tr Ansformation
  • January 2013
    145 pages
  • Germany  

View report >

Pathology Description in Europe

  • Background Paper 6.5 Cancer and Cancer Therapeutics
  • April 2013
    62 pages
  • Cancer  

  • Europe  

    World  

    United States  

View report >

Medinet - Annual Report, 2013

  • Http://www.edgar-online.com
  • January 2013
    171 pages
  • Equity Market  

    Preferred Stock  

    Common Stock  

  • United States  

View report >

Pathology Description

  • Attom: Long-term Effects of Continuing Adjuvant Tamoxifen to 10 ...
  • January 2012
    89 pages
  • Cancer  

    Oncology  

  • United Kingdom  

    France  

View report >

Annual Report, 2014

  • Annual Report 2014
  • January 2014
    53 pages
  • Japan  

    Asia  

View report >
33 reports for Cancer Immunotherapy

Purchase Reports From Reputable Market Research Publishers
(From $ 250 - $ 6 813)

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.